发明名称 Triazolo compounds as MMP inhibitors
摘要 A compound selected from those of formula (I):in which:W represents N or C-R1; in which R1 is as defined in the description,X represents N or C-R2 in which R2 is as defined in the description,Y represents a group selected from oxygen, sulfur, -NH, and -Nalkyl,Z represents a group selected from oxygen, sulphur, -NR8 in which R8 is as defined in the description, and optionally carbon depending the definition of Y,n is an integer from 0 to 8 inclusive,Z1 represents a group -CR9R10 wherein R9 and R10, are as defined in the description, which group contains optionally multiple bonds or heteroatomes,A represents a cyclic group,m is an integer from 0 to 7 inclusive,the group(s) R4 is (are) as defined in the description,R3 represents a group selected from hydrogen, alkyl, alkenyl, alkynyl, and the group of formula:in which p, Z2, B, q, and R13 are as defined in the description,optionally, its racemic forms, isomers thereof, N-oxydes thereof, and its the pharmaceutically acceptable salts thereof, and medicinal products containing the same are useful as specific inhibitors of type-13 matrix mettaloprotease.
申请公布号 US6849637(B2) 申请公布日期 2005.02.01
申请号 US20020075654 申请日期 2002.02.14
申请人 WARNER-LAMBERT COMPANY 发明人 ANDRIANJARA CHARLES;BREUZARD FRANCINE;GAUDILLIERE BERNARD;JACOBELLI HENRI
分类号 A61K31/519;A61P1/02;A61P1/04;A61P9/04;A61P9/10;A61P11/00;A61P11/06;A61P17/06;A61P19/02;A61P19/10;A61P25/00;A61P29/00;A61P35/00;A61P43/00;C07D487/04;(IPC1-7):C07D487/04 主分类号 A61K31/519
代理机构 代理人
主权项
地址
您可能感兴趣的专利